|
Glioblastoma
|
|
|
|
G. Dresemann
Imatinib (STI 571)/ plus hydroxyurea: Safety and efficacy in pre-treated,
progressive Glioblastoma Multiforme (GBM) patients (pts): An update on the
initial 30 pts
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1516.
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1516
|
|
G. Dresemann
Imatinib (STI571) plus hydroxyurea: Safety and
efficacy in pre-treated, progressive glioblastoma multiforme (GBM) patients
(pts)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1550
|
|
G.
Dresemann
STI 571/hydroxyurea in progressive, pretreated
glioblastoma (GB) patients (pts.)
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
465
|
|
|
Glioma
(High Grade)
|
|
|
|
H. S. Friedman, J.
Quinn, J. Rich, J. Vredenburgh, A.
Desjardins, S. Sathornsumetee, A. Salvado,
Z. Nikolova, D. Bigner and D. Reardon
Efficacy of imatinib mesylate plus hydroxyurea regimen in the treatment of
recurrent malignant glioma: Phase II study results
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1515.
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1515
|
|
|
Meningioma
|
|
|
|
Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M,
Rappaport ZH, Fenig E, Ram Z, Sulkes A
Non-resectable slow-growing meningiomas treated by
hydroxyurea
J Neurooncol. 2004 Mar-Apr;67(1-2):221-6.(Abstract+)
|
|
|
Newton HB.
Hydroxyurea chemotherapy in the treatment of meningiomas.
Neurosurg Focus.
2007 Oct;23(4):E11.
Full Text
| 
Reprint
|
|
|
|
